P, N., & K, V. (2019). Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer. Dove Medical Press.
Style de citation Chicago (17e éd.)P, Naruphontjirakul, et Viravaidya-Pasuwat K. Development of Anti-HER2-targeted Doxorubicin–core-shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)P, Naruphontjirakul, et Viravaidya-Pasuwat K. Development of Anti-HER2-targeted Doxorubicin–core-shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.